CAP-XX Limited (LSE:CPX), the Sydney-based maker of ultra-thin supercapacitors quoted on London's AIM market, is not in administration and its shares are not suspended. What it has just done is raise fresh money on punishing terms. On 30 July 2026 the company launched a placing at 0.15 pence, a 31.8% discount to the previous close, and by 4 August it had gathered gross proceeds of roughly £2.3m to expand Manufacturing capacity in Australia.
The key question is whether that cash finally converts a lengthening order book into cash-flow break-even. Unaudited Revenue for the year to 30 June 2026 rose 11% to A$5.24m and bookings jumped almost 35%, yet CAP-XX still reported an EBITDA loss of A$1.13m in the first half alone. With the second Tranche of new shares admitted on 3 September 2026, the company enters FY27 with over 7.4 billion shares in issue.
Fundraise completed: £2.3m raised at 0.15p, shareholders approve second tranche
The most recent material development is the Equity raise announced on 30 July 2026 and completed after a general meeting on 26 August. CAP-XX initially sought £2.0m through a placing and subscription arranged by Allenby Capital, its nominated adviser and sole bookrunner. On 31 July it confirmed it had conditionally raised £2.2m before expenses, and a retail offer added £0.1m, closing oversubscribed on 3 August, for total gross proceeds of approximately £2.3m.
The issue price of 0.15 pence compared with a closing mid-market price of 0.22 pence on 29 July 2026. Roughly 1.5 billion new shares were issued, including 74 million subscription shares taken by directors and the company secretary and 93.3 million shares converting £140,000 of accrued director fees. Chairman Dr Graham Cooley subscribed and converted fees, leaving him with about 9.8% of the enlarged capital; chief executive Lars Stegmann did not participate. The first tranche of 869.6 million shares was admitted on 3 August and the remaining 757.1 million on or around 3 September, taking total voting rights to 7,423,992,457. The company had warned that without the second tranche it "would be unable to execute on its plans for the growth of the Company".
Net proceeds are earmarked for an upgrade to the DMF/DMT production line that supports current sales, an expansion of DMH capacity targeting full production by FY27, a new clean coating room, and the relocation of the Nation Gate product line, with manufacturing repatriated to Australia and customers moved onto existing lines. The board believes "expanded manufacturing capacity and a diversified product range will position the Company to accelerate revenue growth over the coming financial year".
What CAP-XX does
Founded in 1994 and incorporated in Australia, CAP-XX describes itself as a world leader in thin, prismatic supercapacitors and energy management systems. Supercapacitors store and release energy far faster than batteries, and CAP-XX's speciality is packaging that capability into wafer-thin cells. Its catalogue spans ultra-thin prismatic cells, lithium-ion hybrid supercapacitors, coin-cell devices and cylindrical units.
The group manufactures at its headquarters in Seven Hills, Sydney, with device assembly also managed from a site in Malaysia that is now being brought back to Australia. It sells directly and through distributors into aerospace, transportation, green energy, industrial, consumer electronics and defence applications, with an emphasis on Internet of Things devices. Distribution agreements with Farnell (Avnet), RS Components and Waldom Electronics were signed in FY25, and Würth Elektronik was added in 2026. The most significant relationship is with SCHURTER AG, the Swiss components group, which holds roughly 5% of CAP-XX's shares and has launched white-label CAP-XX products under its own brand.
Financial performance: revenue growing, losses narrowing, cash still burning
For the year ended 30 June 2025, audited revenue rose 7.6% to A$4.94m, with gross Margin of 29.7% (FY24: 30.0%). The EBITDA loss narrowed 40.5% to A$3.04m from a restated A$5.11m, and the loss before tax improved 36.0% to A$3.93m. All borrowings were repaid, and year-end cash stood at A$3.96m (June 2024: A$1.76m) after A$5.83m of net equity was raised.
Interim results for the six months to 31 December 2025, published on 2 February 2026, showed revenue up 9% to A$2.63m, a 29% gross margin, an EBITDA loss of A$1.13m (H1 FY25: A$1.21m) and a loss after tax of A$1.53m, or 0.027 Australian cents per share. Bookings rose 31% to A$3.4m and the Backlog more than doubled to A$2.8m. Cash fell to A$2.92m with no debt. "The real story lies in the 31% surge in bookings and our significant A$2.8m order backlog which we are currently delivering," Mr Stegmann said.
Unaudited FY26 figures in the July placing document showed revenue of A$5.24m (up 11%), bookings of A$6.71m (up 34.9%) and a closing backlog of A$3.42m (up 26.7%); no FY26 profit or cash figures have yet been disclosed. At the 0.15p placing price, the enlarged share Capital equates to a Market Value of around £11m.
What could drive the shares next
The first catalyst is the audited FY26 results, expected around November if the company follows its 2025 timetable, which will show whether the EBITDA loss narrowed again in the second half and how much cash remained at 30 June 2026 before the fundraise (LSE:CPX).
Execution of the manufacturing programme is the second. The DMH expansion is targeted at full production by FY27, and transferring Nation Gate customers to Sydney-made products would simplify the cost base. Beyond that, the SCHURTER white-label range and the Würth Elektronik agreement offer routes to markets CAP-XX has struggled to reach alone; any disclosed design wins or Volume orders from those channels would be meaningful against a A$5m revenue base.
Risks investors should watch
Dilution is the defining risk. Shares in issue have risen from 2.9 billion at June 2024 to more than 7.4 billion today, and CAP-XX has repeatedly raised equity to fund losses. With H1 FY26 EBITDA still negative by over A$1m, a further raise cannot be ruled out if growth or margins disappoint; the 31.8% discount accepted in July illustrates the price of capital for a company of this size.
Scale is a structural challenge: FY26 revenue of A$5.24m sits against first-half operating expenses of more than A$3m, and gross margins near 30% leave little cushion against pricing pressure from far larger supercapacitor makers. The manufacturing transfer from Malaysia carries execution and customer-retention risk, the company reports in Australian dollars but trades in sterling, and a sub-penny share price can make the stock Illiquid and volatile.
Outlook
CAP-XX enters FY27 with a replenished balance sheet, a record backlog and a credible industrial partner in SCHURTER, but also with a share count that has more than doubled in two years and a Business yet to prove it can fund itself. The audited FY26 numbers, the pace of the DMH ramp-up and evidence that the enlarged distribution network is producing orders will show whether July's fundraise was the last of its kind or merely the latest.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...